← back to search

Christopher S. King

Virginia Commonwealth University · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Medicine, Intensive care medicine, Interstitial lung disease, Internal medicine, Pulmonary hypertension, and Pulmonary artery.
h-index
citations
6,566
works
14
NIH funding
primary concept
email

Recent publications

Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Thorax 2023cited by 21position: middledoi
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
CHEST Journal 2022cited by 39position: middledoi
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
Pulmonary Circulation 2022cited by 13position: middledoi
Antithrombotic Therapy for VTE Disease
CHEST Journal 2021cited by 938position: middledoi
Executive Summary
CHEST Journal 2021cited by 389position: middledoi
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis
JAMA 2021cited by 78position: middledoi
Lung Transplantation for Patients With COVID-19
CHEST Journal 2021cited by 72position: firstdoi
The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation
Annals of the American Thoracic Society 2021cited by 28position: middledoi
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
Journal of Clinical Medicine 2021cited by 20position: middledoi
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements
The Journal of Heart and Lung Transplantation 2021cited by 12position: middledoi
HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines
Therapeutic Advances in Respiratory Disease 2020cited by 25position: middledoi
Antithrombotic Therapy for VTE Disease
CHEST Journal 2016cited by 4,771position: middledoi
Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis
European Respiratory Journal 2016cited by 67position: middledoi
Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease
Respiratory Medicine 2014cited by 93position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven D. Nathan · Inova Fairfax Hospital7 papers (2014–2023)Janine Vintch · UCLA Medical Center3 papers (2016–2021) · 3 papers (2016–2021)Clive Kearon · McMaster University3 papers (2016–2021)Scott C. Woller · New York University3 papers (2016–2021)Henri Bounameaux · Assistance Publique – Hôpitaux de Paris3 papers (2016–2021)Jonathan H. Chung · Universität Hamburg3 papers (2020–2021)Menno V. Huisman · St. Antonius Ziekenhuis3 papers (2016–2021)Oksana A. Shlobin · Inova Fairfax Hospital3 papers (2014–2021)Scott M. Stevens · Intermountain Healthcare3 papers (2016–2021)Scott D. Barnett · Stanford Medicine2 papers (2020–2021)Peter Smith · University of Toronto2 papers (2022–2023) · 2 papers (2021–2021)Zeenat Safdar · Houston Methodist2 papers (2021–2022)Lisa Baumann Kreuziger · Medical College of Wisconsin2 papers (2021–2021)Namita Sood · Southwestern Medical Center2 papers (2016–2022)Andrew J. Knighton · Intermountain Healthcare2 papers (2021–2021) · 2 papers (2022–2023)Joshua J. Mooney · Palo Alto University2 papers (2021–2021)Shahzad Ahmad · University of Veterinary and Animal Sciences2 papers (2014–2016)